Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry J M Groen

Showing results (21-30 of 274) with videos related to

Pageof 28
Sort By:
AJR. American Journal of Roentgenology|September 24, 2014
Chronic respiratory symptoms associated with airway wall thickening measured by thin-slice low-dose CTXueqian Xie, Akkelies E Dijkstra, Judith M Vonk, et al.
Therapeutics and Clinical Risk Management|March 25, 2008
Cost-effectiveness of hypothetical new cancer drugs in patients with advanced small-cell lung cancer: results of a markov chain modelCarin A Uyl-de Groot, Joseph McDonnell, Guul Ten Velde, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 17, 2018
Assessing Lung Cancer Screening Programs under Uncertainty in a Heterogeneous PopulationHenk Broekhuizen, Catharina G M Groothuis-Oudshoorn, Rozemarijn Vliegenthart, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2013
Pyrosequencing analysis of EGFR and KRAS mutations in EUS and EBUS-derived cytologic samples of adenocarcinomas of the lungJos A Stigt, Nils A 'tHart, Ageeth J Knol, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2004
Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patientsAlena Novakova-Jiresova, Mieke M Van Gameren, Rob P Coppes, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 22, 2019
Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutationsMarscha S Holleman, Maiwenn J Al, Remziye Zaim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2011
18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot studyErwin M Wiegman, Jan Pruim, Jan F Ubbels, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2017
Long-term Outcome of Surgery or Stereotactic Radiotherapy for Lung OligometastasesJoyce E Lodeweges, Theo J Klinkenberg, Jan F Ubbels, et al.
European Radiology|November 5, 2014
The impact of radiologists' expertise on screen results decisions in a CT lung cancer screening trialMarjolein A Heuvelmans, Matthijs Oudkerk, Pim A de Jong, et al.
Clinical Lung Cancer|January 7, 2004
The role of apoptosis-related genes in non-small-cell lung cancerEelco Fokkema, Harry J M Groen, Coby Meijer, et al.
Pageof 28

Showing results (21-30 of 274) with videos related to

Sort By:
Pageof 28
AJR. American Journal of Roentgenology|September 24, 2014
Chronic respiratory symptoms associated with airway wall thickening measured by thin-slice low-dose CTXueqian Xie, Akkelies E Dijkstra, Judith M Vonk, et al.
Therapeutics and Clinical Risk Management|March 25, 2008
Cost-effectiveness of hypothetical new cancer drugs in patients with advanced small-cell lung cancer: results of a markov chain modelCarin A Uyl-de Groot, Joseph McDonnell, Guul Ten Velde, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 17, 2018
Assessing Lung Cancer Screening Programs under Uncertainty in a Heterogeneous PopulationHenk Broekhuizen, Catharina G M Groothuis-Oudshoorn, Rozemarijn Vliegenthart, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2013
Pyrosequencing analysis of EGFR and KRAS mutations in EUS and EBUS-derived cytologic samples of adenocarcinomas of the lungJos A Stigt, Nils A 'tHart, Ageeth J Knol, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2004
Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patientsAlena Novakova-Jiresova, Mieke M Van Gameren, Rob P Coppes, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 22, 2019
Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutationsMarscha S Holleman, Maiwenn J Al, Remziye Zaim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2011
18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot studyErwin M Wiegman, Jan Pruim, Jan F Ubbels, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2017
Long-term Outcome of Surgery or Stereotactic Radiotherapy for Lung OligometastasesJoyce E Lodeweges, Theo J Klinkenberg, Jan F Ubbels, et al.
European Radiology|November 5, 2014
The impact of radiologists' expertise on screen results decisions in a CT lung cancer screening trialMarjolein A Heuvelmans, Matthijs Oudkerk, Pim A de Jong, et al.
Clinical Lung Cancer|January 7, 2004
The role of apoptosis-related genes in non-small-cell lung cancerEelco Fokkema, Harry J M Groen, Coby Meijer, et al.
Pageof 28